Publicatie

Publicatie datum

Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease.

Dankers, M., Nelissen-Vrancken, M.H.J.M.G., Surminski, S.M.K., Lambooij, A.C., Schermer, T.R., Dijk, L. van. Healthcare Professionals' Preferred Efficacy Endpoints and Minimal Clinically Important Differences in the Assessment of New Medicines for Chronic Obstructive Pulmonary Disease. Frontiers in Pharmacology: 2020
Lees online